Medical News

RSS

Sunesis Pharmaceuticals raises $5.0 million through private placement

Sunesis Pharmaceuticals, Inc. today announced the closing of a private placement of $5.0 million of units consisting of convertible preferred stock and common stock warrants on October 30, 2009. This closing constitutes the second tranche of the private placement of up to $43.5 million of Sunesis' securities announced in April 2009.

2 Nov 2009

Valeant Pharmaceuticals announces financial results for the third quarter of 2009

Valeant Pharmaceuticals International today announced third quarter financial results for 2009.

2 Nov 2009

PDI selects Veeva System’s CRM suite of multi-tenant SaaS applications

PDI, Inc., a leading provider of sales and marketing support to U.S. pharmaceutical companies, selected Veeva System’s VBioPharma CRM Primary Care and Special Care Editions, VMobile, and VInsights – all part of the Veeva CRM suite of multi-tenant SaaS applications. This marks PDI’s continued commitment to the technology advances in the world of cloud computing where business spending on SaaS/Cloud applications is expected to rise 22% this year to $9.6 billion, according to Gartner.

2 Nov 2009

Court upholds AGA Medical’s patent, grants injunction against Occlutech's Figulla Flex occluders

AGA Medical Holdings, Inc. today announced that the German Regional Court in Düsseldorf, Germany has granted a preliminary injunction against the manufacture, possession and sale of the Figulla® Flex occluders manufactured by Occlutech GmbH in Jena, Germany.

2 Nov 2009

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

November is Epilepsy Awareness Month. The Lennox Gastaut Syndrome Foundation (LGSF) and the American Epilepsy Outreach Foundation (AEOF) has joined with Eisai Pharmaceuticals and Lundbeck Pharmaceuticals to co-host the 1st Annual Helmets for Hope(TM) Campaign.

2 Nov 2009

Results of review by Marwood Group Advisory released by Amedisys

Amedisys, Inc., one of America's leading home health and hospice nursing companies, today released the results of a review conducted by Marwood Group Advisory, LLC (Marwood). Several months ago Amedisys engaged Marwood, one of the nation’s preeminent health care consulting firms, to provide an independent analysis of the Company’s procedures, controls, clinical infrastructure, corporate compliance processes, technology offerings and future strategies.

2 Nov 2009

VEGF from the retinal pigment epithelium to the choriocapillaris leads to degeneration of the CC, study finds

Scientists at Schepens Eye Research Institute have found that when the eye is missing a diffusible form of vascular endothelial growth factor (VEGF), i.e. one that when secreted can reach other cells at a distance, the retina shows defects similar to "dry" macular degeneration, also called geographic atrophy (GA).

2 Nov 2009

Poor managerial leadership linked with the amont of sick leave taken at workplace

Perceived poor managerial leadership increases not only the amount of sick leave taken at a workplace, but also the risk of sickness amongst employees later on in life. The longer a person has had a "poorer" manager, the higher his or her risk of for example suffering a heart attack within a ten-year period, according to a new thesis from the Swedish medical university Karolinska Institutet.

2 Nov 2009

Perrigo announces financial results for the first quarter of fiscal 2010

Perrigo Company today announced results for its first quarter ended September 26, 2009.

2 Nov 2009

Perrigo to sell its Israel Consumer Products business to Emilia Group

Perrigo Company today announced that it has signed a definitive agreement to sell its Israel Consumer Products business along with the related production assets in Israel to Emilia Group, a subsidiary of O. Feller Holdings Ltd., for 205 million New Israeli Shekels (approximately $54 million).

2 Nov 2009

Arrayit Corporation joins federal government in their efforts to help control health care costs

Arrayit Corporation is pleased to join the federal government in their efforts to help control health care costs by leveraging Arrayit's leading edge health care platform.

2 Nov 2009

Avila Therapeutics presents preclinical study data of its AVL-181 HCV protease inhibitor

Avila Therapeutics™, Inc., a biotechnology company developing novel covalent drugs that treat diseases through protein silencing, presented results of preclinical studies on its highly selective, small molecule Hepatitis C Virus (HCV) protease inhibitor, AVL-181. Avila showed that AVL-181 promoted complete viral clearance in vitro when used at clinically-relevant concentrations in combination with other HCV therapies.

2 Nov 2009

New on-line job resource center launched by NAWC

The National Alliance of Wound Care (NAWC(®)), the largest, multi-disciplinary, wound care credentialing and association organization, announced today, the launch of their wound care specialty on-line Job Resource Center in conjunction with their newly redesigned website at, www.nawccb.org.

2 Nov 2009

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (“The Liver Meeting”).

2 Nov 2009

Historic agreement sets national standard for containing the spread of H1N1

In a dramatic settlement seen as a novel pattern for the nation, the nation's largest nurses union and professional association, and one of the country's biggest hospital systems today announced a landmark agreement that sets a national standard on containing the spread of pandemics such as H1N1 "swine flu."

2 Nov 2009

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced positive efficacy data from a Phase 2 study with its targeted cytotoxic peptide conjugate, AEZS-108 (formerly AN-152), in patients with platinum-resistant and taxane-pretreated ovarian cancer.

2 Nov 2009

Kinetic Concepts receives approval from MHLW in Japan to sell its V.A.C. Therapy System

Kinetic Concepts, Inc. announced today that the Ministry of Health, Labor and Welfare (MHLW) in Japan has granted final regulatory approval for KCI to market and sell its innovative V.A.C.® Therapy System in the country.

2 Nov 2009

Vanda Pharmaceuticals announces financial results for the third quarter of 2009

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of clinical-stage products for central nervous system disorders, today announced financial and operational results for the third quarter ended September 30, 2009.

2 Nov 2009

First Edition: November 2, 2009

Today's headlines feature insights into President Obama's behind-the-scenes role in advancing the Democrats' health overhaul efforts in Congress, plus more analysis of the public insurance option.

2 Nov 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Pulmatrix, a clinical stage biotechnology company discovering and developing a new class of therapies for the treatment and prevention of infectious and progressive respiratory diseases, today announced that it has been awarded a grant for $2.2 million from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), aimed at advancing the development of novel influenza therapeutics for the treatment of seasonal and pandemic influenza.

2 Nov 2009

Medical News

Sunesis Pharmaceuticals raises $5.0 million through private placement

Valeant Pharmaceuticals announces financial results for the third quarter of 2009

PDI selects Veeva System’s CRM suite of multi-tenant SaaS applications

Court upholds AGA Medical’s patent, grants injunction against Occlutech's Figulla Flex occluders

"Helmets for Hope" campaign launched to raise epilepsy disorder awareness

Results of review by Marwood Group Advisory released by Amedisys

VEGF from the retinal pigment epithelium to the choriocapillaris leads to degeneration of the CC, study finds

Poor managerial leadership linked with the amont of sick leave taken at workplace

Perrigo announces financial results for the first quarter of fiscal 2010

Perrigo to sell its Israel Consumer Products business to Emilia Group

Arrayit Corporation joins federal government in their efforts to help control health care costs

Avila Therapeutics presents preclinical study data of its AVL-181 HCV protease inhibitor

New on-line job resource center launched by NAWC

Alnylam Pharmaceuticals presents new data from its transthyretin-mediated amyloidosis program

Historic agreement sets national standard for containing the spread of H1N1

Positive results from Aeterna Zentaris' AEZS-108 Phase 2 study in ovarian cancer patients

Kinetic Concepts receives approval from MHLW in Japan to sell its V.A.C. Therapy System

Vanda Pharmaceuticals announces financial results for the third quarter of 2009

First Edition: November 2, 2009

NIAID awards Pulmatrix $2.2M grant for developing novel influenza therapeutics

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News